VIVAZOME THERAPEUTICS

VivaZome Therapeutics is Australian biotech company,

#SimilarOrganizations #Website #More

VIVAZOME THERAPEUTICS

Social Links:

Industry:
Biotechnology

Founded:
2016-01-01

Address:
Carlton, Victoria, Australia

Country:
Australia

Website Url:
http://www.vivazome.com

Total Employee:
1+

Status:
Active

Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro LetsEncrypt SSL By Default Mobile Non Scaleable Content IPv6 Google Common Name Invalid CPanel


Similar Organizations

factor-therapeutics-ltd-logo

Factor Therapeutics Ltd.

Factor Therapeutics Ltd. is an Australian biotechnology company

not_available_image

Rekindle Therapeutics

Rekindle Therapeutics is a biotechnology company.

not_available_image

RNADerm Therapeutics

RNADerm Therapeutics is a biotechnology company.

Official Site Inspections

http://www.vivazome.com

  • Host name: syn03bd.syd6.hostyourservices.net
  • IP address: 110.232.143.35
  • Location: Brisbane Australia
  • Latitude: -27.4732
  • Longitude: 153.0215
  • Timezone: Australia/Brisbane
  • Postal: 4000

Loading ...

More informations about "VivaZome Therapeutics"

VivaZome - Novel biological therapies for serious diseases

VivaZome is delighted to announce a suite of positive changes to the company’s board and executive team. Xenia Sango has been promoted to CEO and Managing Director, David …See details»

ABOUT US – VivaZome Therapeutics

The Board and Management of VivaZome Therapeutics – Ian Nisbet, Craig Newton, Anthony Filippis, Xenia Sango and David Haylock – have over 150 years of combined biotech, cell biology and pharmaceutical experience with activity …See details»

Member Directory - BioMelbourne Network

VivaZome Therapeutics Pty Ltd (ABN 59 602 230 964) is a privately-held Australian biotech company, based in Melbourne, Victoria. VivaZome was formed to develop and commercialise …See details»

Our mission – Old – VivaZome Therapeutics

VivaZome’s mission is: To be a global leader in providing novel, valuable and safe exosome-derived therapies for debilitating and life-threatening diseases. VivaZome business is based …See details»

Vivazome - Biotech Careers

VivaZome aims to develop and commercialize exosome-based therapies for debilitating and life-threatening disorders, with a focus on neurological disorders, retinal disease and ischaemic …See details»

VivaZome Therapeutics - Crunchbase Company Profile & Funding

View contacts for VivaZome Therapeutics to access new leads and connect with decision-makers. Where is VivaZome Therapeutics's headquarters? VivaZome Therapeutics is located in …See details»

VivaZome to collaborate with ANU retinal disease experts to …

Jan 27, 2022 · VivaZome Therapeutics Pty Ltd has announced its participation in a collaborative project with researchers at the Australian National University (ANU) and other expert groups …See details»

Pioneering disease-fighting cell technology - La Trobe …

Australian biotech company VivaZome Therapeutics' partnership with La Trobe University helps fund mission to pioneer next-generation manufacturing pipelines for advanced therapies.See details»

ReNerve and VivaZome Enter Collaboration in Spinal Cord Repair

May 25, 2021 · ReNerve Ltd (ReNerve) and VivaZome Therapeutics Pty Ltd (VivaZome) today announced that they have entered a collaboration to combine their leading scaffold and …See details»

OUR TECHNOLOGY – VivaZome Therapeutics

VivaZome is leveraging the best that nature and technology has to offer: Cell Source is key; exploit unique cell attributes. Multiple cells types screened based on their native biological function. Exosome quantity and quality assessed. …See details»

New research to develop therapeutics - La Trobe University

La Trobe University and VivaZome Therapeutics Pty Ltd have announced a new collaborative research project focused on developing novel exosome therapeutics. Under the collaborative …See details»

Cytiva fuels biotech development in Australia and New Zealand

Feb 2, 2022 · VivaZome aims to develop and commercialize exosome-based therapies for debilitating and/or life-threatening disorders, with an initial focus on ischemia, fibrotic disease …See details»

VivaZome Therapeutics - Products, Competitors, Financials, …

Aug 25, 2023 · VivaZome Therapeutics is a biotech company focused on the development and commercialization of novel biological therapies for serious diseases. Use the CB Insights …See details»

CONTACT US – VivaZome Therapeutics

Our first focus is on diseases associated with neuro-inflammation with a particular focus on Age-related Macular Degeneration (AMD) and Post-Traumatic Epilepsy (PTE).See details»

VivaZome - La Trobe University

VivaZome relocates to La Trobe University’s Bio Innovation Hub to advance neuro-inflammatory disease research. Through their partnership, VivaZome and La Trobe University aim to …See details»

Excellence in Exosome Therapy - biomelbourne.org

May 21, 2020 · VivaZome Therapeutics Pty Ltd (ABN 59 602 230 964) is a privately held Australian biotech company, with headquarters at the La Trobe University Technology …See details»

VivaZome Therapeutics - Overview, News & Similar companies

Jan 31, 2022 · VivaZome Therapeutics contact info: Phone number: +61 431709121 Website: www.vivazome.com What does VivaZome Therapeutics do? VivaZome Therapeutics Pty Ltd …See details»

VivaZome executives to present at Annual Exosome Scientific …

Nov 3, 2022 · About VivaZome: VivaZome Therapeutics Pty Ltd is a privately-held Australian biotech company, with operational headquarters at the La Trobe University Technology …See details»

Vivazome - VentureRadar

Website: https://vivazome.com/ Develops innovative, safe exosome-derived therapies for severe and life-threatening diseases, primarily focusing on ischaemic diseases and peripheral arterial …See details»

VivaZome and ReNerve to collaborate on nerve repair

Jun 20, 2020 · ReNerve and VivaZome have entered a collaboration to combine their leading scaffold and exosome technologies, skills and experience to explore new solutions for the …See details»

linkstock.net © 2022. All rights reserved